197 related articles for article (PubMed ID: 34238603)
1. Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving.
Chomsky-Higgins Menut K; Pearlstein SS; Conroy PC; Roman SA; Shen WT; Gosnell J; Sosa JA; Duh QY; Suh I
Surgery; 2022 Jan; 171(1):96-103. PubMed ID: 34238603
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness Analysis of Preoperative Screening Strategies for Obstructive Sleep Apnea among Patients Undergoing Elective Inpatient Surgery.
Sankar A; Dixon PR; Sivanathan L; Memtsoudis SG; de Almeida JR; Singh M
Anesthesiology; 2020 Oct; 133(4):787-800. PubMed ID: 32930728
[TBL] [Abstract][Full Text] [Related]
3. Screening for Primary Aldosteronism is Underutilized in Patients with Obstructive Sleep Apnea.
Conroy PC; Hernandez S; Graves CE; Menut KC; Pearlstein S; Liu C; Shen WT; Gosnell J; Sosa JA; Roman S; Duh QY; Suh I
Am J Med; 2022 Jan; 135(1):60-66. PubMed ID: 34508708
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis.
Woode ME; Wong K; Reid CM; Stowasser M; Russell G; Gwini S; Young MJ; Fuller PJ; Yang J; Chen G
J Hypertens; 2023 Oct; 41(10):1615-1625. PubMed ID: 37466447
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
[TBL] [Abstract][Full Text] [Related]
6. Implementation of a formal sleep center-based screening protocol for primary aldosteronism in patients with obstructive sleep apnea.
Wright K; Mahmoudi M; Agrawal N; Simpson H; Lui MS; Pachter HL; Patel K; Prescott J; Suh I
Surgery; 2023 Jan; 173(1):59-64. PubMed ID: 36198493
[TBL] [Abstract][Full Text] [Related]
7. Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives.
Ruhle BC; White MG; Alsafran S; Kaplan EL; Angelos P; Grogan RH
Surgery; 2019 Jan; 165(1):221-227. PubMed ID: 30415872
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of obstructive sleep apnea screening for patients with diabetes or chronic kidney disease.
Okubo R; Kondo M; Hoshi SL; Yamagata K
Sleep Breath; 2015 Sep; 19(3):1081-92. PubMed ID: 25643768
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of screening for primary aldosteronism in China.
Li N; Huang J; Zheng B; Cai H; Liu M; Liu L
Clin Endocrinol (Oxf); 2021 Sep; 95(3):414-422. PubMed ID: 33837588
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan.
Sato M; Morimoto R; Seiji K; Iwakura Y; Ono Y; Kudo M; Satoh F; Ito S; Ishibashi T; Takase K
Horm Metab Res; 2015 Oct; 47(11):826-32. PubMed ID: 26305168
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.
Tan MC; Ayas NT; Mulgrew A; Cortes L; FitzGerald JM; Fleetham JA; Schulzer M; Ryan CF; Ghaeli R; Cooper P; Marra CA
Can Respir J; 2008 Apr; 15(3):159-65. PubMed ID: 18437259
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of population-based screening for diabetes and hypertension in India: an economic modelling study.
Kaur G; Chauhan AS; Prinja S; Teerawattananon Y; Muniyandi M; Rastogi A; Jyani G; Nagarajan K; Lakshmi P; Gupta A; Selvam JM; Bhansali A; Jain S
Lancet Public Health; 2022 Jan; 7(1):e65-e73. PubMed ID: 34774219
[TBL] [Abstract][Full Text] [Related]
15. Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study.
Hundemer GL; Imsirovic H; Kendzerska T; Vaidya A; Leung AA; Kline GA; Goupil R; Madore F; Agharazii M; Knoll G; Sood MM
Am J Hypertens; 2023 Jun; 36(7):363-371. PubMed ID: 36827468
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study.
Trenaman L; Sadatsafavi M; Almeida F; Ayas N; Lynd L; Marra C; Stacey D; Bansback N
Med Decis Making; 2015 Jul; 35(5):671-82. PubMed ID: 25344130
[TBL] [Abstract][Full Text] [Related]
17. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.
Pietzsch JB; Garner A; Cipriano LE; Linehan JH
Sleep; 2011 Jun; 34(6):695-709. PubMed ID: 21629357
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial.
Pietzsch JB; Liu S; Garner AM; Kezirian EJ; Strollo PJ
Sleep; 2015 May; 38(5):735-44. PubMed ID: 25348126
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
